Alfaro Jorge, Espinoza Arturo, Manŕiquez María, Moyano Leonor, González Néstor, Larrondo Milton, Figueroa Gastón
Laboratorio de Terapia Celular, Banco de Sangre, Hospital Clínico de la Universidad de Chile, Santiago de Chile.
Rev Med Chil. 2004 Nov;132(11):1403-6. doi: 10.4067/s0034-98872004001100010.
We report a 78 year old male with prostatism, that was subjected to a prostate biopsy. The pathological study showed a microvascular lymphocytic infiltration. Four months later, the patients presented with reduced alertness, cough, dyspnea, fever and elevation of lactic dehydrogenase and erythrocyte sedimentation rate. Chest and abdominal CAT scans, bone marrow aspirate, protein electrophoresis and prostate specific antigen were normal. A re-evaluation of prostate biopsy showed an intravascular lymphoid infiltration, positive for CD45 and CD20, compatible with the diagnosis of intravascular lymphoma. Chemotherapy was started, but it was not tolerated by the patient and the response was partial. Therefore, treatment with monoclonal antibodies anti CD20 (Rituximab) was started. The tumor had a complete and prolonged (24 months) remission after the treatment
我们报告了一名78岁患有前列腺增生的男性患者,该患者接受了前列腺活检。病理研究显示微血管淋巴细胞浸润。四个月后,患者出现警觉性降低、咳嗽、呼吸困难、发热以及乳酸脱氢酶和红细胞沉降率升高。胸部和腹部计算机断层扫描、骨髓穿刺、蛋白电泳以及前列腺特异性抗原检查均正常。对前列腺活检进行重新评估显示血管内淋巴细胞浸润,CD45和CD20呈阳性,符合血管内淋巴瘤的诊断。开始进行化疗,但患者无法耐受,且反应为部分缓解。因此,开始使用抗CD20单克隆抗体(利妥昔单抗)进行治疗。治疗后肿瘤实现了完全且持久(24个月)的缓解。